COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
11 hedge funds and large institutions have $71.4K invested in COSCIENS Biopharma Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more capital invested
Capital invested by funds: $71.4K → $71.4K (+$27)
0% more ownership
Funds ownership: 0.14% → 0.14% (+0%)
8% less funds holding
Funds holding: 12 → 11 (-1)
92% less call options, than puts
Call options by funds: $47K | Put options by funds: $567K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.3K |
| 2 |
JP Morgan Chase
New York
|
+$228 |
| 3 |
Morgan Stanley
New York
|
+$137 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$365 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $41.7K | +$137 | +12 | +0.3% |
|
|
EDRH
2
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $10.3K | – | – | – |
|
3
Group One Trading
Chicago,
Illinois
| $7.68K | – | – | – |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $7K | +$2.3K | +202 | +47% |
|
|
5
JP Morgan Chase
New York
| $1.33K | +$228 | +20 | +10% |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.03K | – | – | – |
|
|
7
National Bank of Canada
Montreal,
Quebec, Canada
| $843 | -$365 | -32 | -27% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $609 | – | – | – |
|
9
Wells Fargo
San Francisco,
California
| $521 | – | – | – |
|
|
TC
10
Truvestments Capital
Sarasota,
Florida
| $227 | – | – | – |
|
|
FWM
11
Focused Wealth Management
Newburgh,
New York
| $155 | – | – | – |
|
|
IGWM
12
ICA Group Wealth Management
Denver,
Colorado
| $3 | – | – | – |
|
CSCI Hedge Fund Activity: Q2 2023 in Review
11 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q2 2023, worth a combined $71.4K — up 0.04% from $71.4K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CSCI and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Royal Bank of Canada, adding an estimated $2.3K. The largest seller was National Bank of Canada, cutting an estimated $365.
- 11 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q2 2023, down from 12 in Q1 2023.
- Funds reported $71.4K of COSCIENS Biopharma Inc. Common Stock stock for Q2 2023, up 0.04% quarter-over-quarter.
- 0 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q2 2023 was Royal Bank of Canada, an estimated $2.3K added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q2 2023 was National Bank of Canada, an estimated $365 sold.
Based on aggregated 13F filings for Q2 2023.